Neurogene Inc (NGNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -90,351 | -75,144 | -36,317 | -55,189 | -60,692 |
| Depreciation Amortization | -1,444 | 828 | 3,192 | 3,200 | 2,277 |
| Accounts payable and accrued liabilities | 627 | -77 | 667 | -3,607 | N/A |
| Other Working Capital | 268 | -5,961 | -4,023 | -2,695 | -700 |
| Other Operating Activity | 13,727 | 9,751 | -14,941 | 5,467 | 11,557 |
| Operating Cash Flow | $-77,173 | $-70,603 | $-51,422 | $-52,824 | $-47,558 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,183 | -808 | -321 | -2,230 | -3,263 |
| Purchase Of Investment | -269,513 | -198,453 | N/A | N/A | 0 |
| Sale Of Investment | 284,700 | 74,000 | 5,000 | N/A | N/A |
| Other Investing Activity | 0 | 0 | 20,958 | 0 | 0 |
| Investing Cash Flow | $14,004 | $-125,261 | $25,637 | $-2,230 | $-3,263 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 92,343 | N/A | N/A |
| Debt Repayment | -61 | -52 | -29 | -1 | -51 |
| Common Stock Issued | 30,730 | 191,265 | 168 | 73 | 783 |
| Other Financing Activity | -241 | -7,142 | 0 | 66,459 | 0 |
| Financing Cash Flow | $30,428 | $184,071 | $92,482 | $66,531 | $732 |
| Beginning Cash Position | 136,925 | 148,718 | 82,021 | 70,544 | 193,434 |
| End Cash Position | 104,184 | 136,925 | 148,718 | 82,021 | 143,345 |
| Net Cash Flow | $-32,741 | $-11,793 | $66,697 | $11,477 | $-50,089 |
| Free Cash Flow | |||||
| Operating Cash Flow | -77,173 | -70,603 | -51,422 | -52,824 | -47,558 |
| Capital Expenditure | -1,183 | -808 | -321 | -2,230 | -3,263 |
| Free Cash Flow | -78,356 | -71,411 | -51,743 | -55,054 | -50,821 |